TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19

NCT04573855 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

D'Or Institute for Research and Education